Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Cognitive Bias Modification for Interpretation (CBM-I) on Pain Severity and Interference in People With Type 2 Diabetes and Persistent Pain

NCT06908486 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT06908486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06908486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Cognitive Bias Modification for Interpretation (CBM-I) on Pain Severity and Interference in People With Type 2 Diabetes and Persistent Pain
Lead sponsor
University of Sydney
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2025
Completion date
October 15, 2025
Enrollment
319 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent pain, type 2 diabetes